✦ LIBER ✦

Efficacy of a new magnet-driven liposomal form of prednisolone in the treatment of experimental allergic dermatitis

✍ Scribed by G. K. Ismailova; V. I. Efremenko; I. V. Savel’eva; O. V. logvinenko

Book ID: 106491512
Publisher: Springer
Year: 2006
Tongue: English
Weight: 360 KB
Volume: 40
Category: Article
ISSN: 0091-150X
DOI: 10.1007/s11094-006-0086-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of a new topical cyclosporine A

Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs

✍ Puigdemont, Anna; Brazís, Pilar; Ordeix, Laura; Dalmau, Annabel; Fuertes, Esther 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 584 KB

Efficacy of high loading doses of liposo

Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis

✍ J. Gavaldà; T. Martín; P. López; X. Gomis; J. L. Ramírez; D. Rodríguez; Ó. Len; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Establishing Efficacy of a New Experimen

Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design

✍ Dieter Hauschke; Iris Pigeot 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

Rejoinder to “Establishing Efficacy of a

Rejoinder to “Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design”

✍ Dieter Hauschke; Iris Pigeot 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

Discussion on “Establishing Efficacy of

Discussion on “Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design”

✍ H. M. James Hung 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 1 views

Discussion on “Establishing Efficacy of

Discussion on “Establishing Efficacy of a New Experimental Treatment in the ‘Gold Standard’ Design”

✍ Armin Koch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

We are grateful that Hauschke and Pigeot (2005) elaborate a little on our (Koch and Raehmel, 2004) considerations on what may constitute under which circumstances a valid proof of efficacy for a new experimental treatment as compared to a reference and placebo in a so-called "gold standard design".